Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PAZNTIS: Pazopanib Neoadjuvant Trial in Non-Rhabdomyosarcoma Soft Tissue Sarcomas
NCT02180867Phase 3Completed
- Sponsor
- National Cancer Institute
- Start
- Aug 2014
- Primary completion
- Jun 2019
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 3 trial of pazopanib in soft tissue sarcoma (STS), sponsored by National Cancer Institute. Started Aug 2014; status: completed.
02
Drugs
pazopanib
03
Conditions
soft tissue sarcoma (STS)
Beyond the preview
Go deeper on NCT02180867.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02180867.